🎉 M&A multiples are live!
Check it out!

Adlai Nortye Valuation Multiples

Discover revenue and EBITDA valuation multiples for Adlai Nortye and similar public comparables like Galapagos, Pharming, and Benevolent AI.

Adlai Nortye Overview

About Adlai Nortye

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.


Founded

2004

HQ

United States of America
Employees

127

Website

adlainortye.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

-$17.0M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Adlai Nortye Financials

Adlai Nortye has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Adlai Nortye achieved revenue of $5.0M and an EBITDA of -$101M.

Adlai Nortye expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Adlai Nortye valuation multiples based on analyst estimates

Adlai Nortye P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a $5.0M XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$56.3M -$101M XXX XXX XXX
EBITDA Margin -Infinity% -2024% XXX XXX XXX
Net Profit -$56.7M -$58.8M XXX XXX XXX
Net Margin -Infinity% -1176% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Adlai Nortye Stock Performance

As of April 15, 2025, Adlai Nortye's stock price is $2.

Adlai Nortye has current market cap of $76.6M, and EV of -$17.0M.

See Adlai Nortye trading valuation data

Adlai Nortye Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
-$17.0M $76.6M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Adlai Nortye Valuation Multiples

As of April 15, 2025, Adlai Nortye has market cap of $76.6M and EV of -$17.0M.

Adlai Nortye's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Adlai Nortye's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Adlai Nortye and 10K+ public comps

Adlai Nortye Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV -$17.0M XXX XXX XXX
EV/Revenue -3.4x XXX XXX XXX
EV/EBITDA 0.2x XXX XXX XXX
P/E -0.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 0.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Adlai Nortye Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Adlai Nortye Valuation Multiples

Adlai Nortye's NTM/LTM revenue growth is n/a

Adlai Nortye's revenue per employee for the last fiscal year averaged $39K, while opex per employee averaged $0.6M for the same period.

Over next 12 months, Adlai Nortye's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Adlai Nortye's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Adlai Nortye and other 10K+ public comps

Adlai Nortye Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth Infinity% XXX XXX XXX XXX
EBITDA Margin -2024% XXX XXX XXX XXX
EBITDA Growth 80% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $39K XXX XXX XXX XXX
Opex per Employee $0.6M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 306% XXX XXX XXX XXX
R&D Expenses to Revenue 1163% XXX XXX XXX XXX
Opex to Revenue 1451% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Adlai Nortye Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Adlai Nortye M&A and Investment Activity

Adlai Nortye acquired  XXX companies to date.

Last acquisition by Adlai Nortye was  XXXXXXXX, XXXXX XXXXX XXXXXX . Adlai Nortye acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Adlai Nortye

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Adlai Nortye

When was Adlai Nortye founded? Adlai Nortye was founded in 2004.
Where is Adlai Nortye headquartered? Adlai Nortye is headquartered in United States of America.
How many employees does Adlai Nortye have? As of today, Adlai Nortye has 127 employees.
Who is the CEO of Adlai Nortye? Adlai Nortye's CEO is Mr. Yang Lu.
Is Adlai Nortye publicy listed? Yes, Adlai Nortye is a public company listed on NAS.
What is the stock symbol of Adlai Nortye? Adlai Nortye trades under ANL ticker.
When did Adlai Nortye go public? Adlai Nortye went public in 2023.
Who are competitors of Adlai Nortye? Similar companies to Adlai Nortye include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Adlai Nortye? Adlai Nortye's current market cap is $76.6M
Is Adlai Nortye profitable? Yes, Adlai Nortye is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.